News
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
The U.S. Food and Drug Administration has approved a groundbreaking HIV prevention shot that only needs to be taken twice a year. Medical experts are calling it one of the most significant ...
1d
Audacy on MSNThere's a new, highly effective HIV drug on the marketA revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Results are available in 20 to 40 minutes. According to the Food and Drug Administration (FDA), the OraQuick In-Home HIV test measured at about 92 percent accuracy at detecting HIV. But about 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results